Moderna Inc (MRNA) is a Healthcare · Biotechnology company listed on NASDAQ. Price $154.04 (-2.55%), Market cap $18.75B, 52-week low–high $22.36 ~ $57.80.
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, i
Financial statements, price targets, institutional (13F) holdings and related news for Moderna Inc are updated in real time on BlackAll Trade.
Moderna Inc trades at $154.04 (-2.55%). Real-time quotes and charts are available on BlackAll Trade.
Moderna Inc has a market cap of about $18.75B.
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COV